Back To Results

Treatment

June 30, 2017

NPF Sponsored Videos: TREMFYA® (guselkumab): A first-line biologic in adult patients with moderate to severe plaque psoriasis, also approved for adults with active psoriatic arthritis

Sponsored by Janssen Biotech, Inc. View full prescribing information here.

Share
Related Items

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorMy Psoriasis Team logo

Copyright © 1996-2020 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.